Emerging Markets to Drive Growth for Biopsy Devices
The biopsy devices market has benefitted from being suitable for the diagnosis of a variety of cancer indications, and will grow from $506.4m in 2013 to $602.4m in 2019, at a global compound annual growth rate (CAGR) of 2.93%.
The fastest-growing segment within the global biopsy devices market will be core needle biopsy (BNB) devices, with a CAGR of 4.14% worldwide. This segment will increase from $189.4m in 2013 to $241.6m in 2019.
The Fine Needle Aspiration (FNA) devices market will have a growth rate similar to CNB devices, with a CAGR of 3.87%. This segment will increase from $75.4m in 2013 to $94.7m in 2019.
Download to read more.